October 22, 2025

Treating Female Hair Loss: What Are the Options?

Low-dose oral minoxidil showed comparable effectiveness to 5% topical minoxidil in treating female-pattern hair loss.

Conexiant

October 20, 2025

Which Hair Loss Treatments Truly Deliver Results?

Researchers compare prescription and over-the-counter treatments for male hair loss to determine which best improve hair density.

Conexiant

October 09, 2025

Medical Oddities: What Your Sleep Says About You

Five stories span sleep neuroscience, anti-aging dog training, a citrus misdiagnosis, green tea’s post-op benefits, and a gummy binge gone wrong.

Conexiant

October 06, 2025

Dupilumab Shows High Treatment Persistence in AD

Biologics target type 2 inflammation in atopic dermatitis, improving skin barrier and symptoms.

Conexiant

October 03, 2025

Court Upholds State's "Doctor" Title Ban

Federal judge rules nurse practitioners with doctorates cannot use “doctor/Dr.” in advertising or health care settings likely to make patients think they’re physicians. 

Conexiant

October 01, 2025

How Safe Are FDA-Cleared AI Tools?

“These findings indicate that standardized efficacy, safety, and risk assessment reporting remains inadequate for FDA-cleared AI/ML devices, underscoring the need for dedicated regulatory pathways and robust postmarket surveillance to ensure patient safety."

Conexiant

October 01, 2025

Remibrutinib Gains FDA Nod for Urticaria

First oral BTK inhibitor approved for antihistamine-resistant chronic spontaneous urticaria, targeting mast cell–driven immune dysregulation

Conexiant

September 30, 2025

Physician Shortages Loom Amid Policy Shifts

Health care drives the year’s employment growth—yet limits on immigrant labor and looming Medicaid reductions could sap momentum and leave hospitals and home care struggling to hire.

KFF Health News

September 30, 2025

Multiple Suits: Red Flag or Noise?

Cosmetic surgery chains expanded with emergency-licensed, out-of-state surgeons; lawsuits and disciplinary records challenge credentialing, “fellowship” claims, and patient protections in an industry without public complication tracking.

KFF Health News